Abo Bibliothek: Guest
Critical Reviews™ in Immunology

Erscheint 6 Ausgaben pro Jahr

ISSN Druckformat: 1040-8401

ISSN Online: 2162-6472

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 1.3 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 2.6 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00079 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.24 SJR: 0.429 SNIP: 0.287 CiteScore™:: 2.7 H-Index: 81

Indexed in

New Technologies in Using Recombinant Attenuated Salmonella Vaccine Vectors

Volumen 30, Ausgabe 3, 2010, pp. 255-270
DOI: 10.1615/CritRevImmunol.v30.i3.30
Get accessGet access

ABSTRAKT

Recombinant attenuated Salmonella vaccines (RASVs) have been constructed to deliver antigens from other pathogens to induce immunity to those pathogens in vaccinated hosts. The attenuation means should ensure that the vaccine survives following vaccination to colonize lymphoid tissues without causing disease symptoms. This necessitates that attenuation and synthesis of recombinant gene encoded protective antigens do not diminish the ability of orally administered vaccines to survive stresses encountered in the gastrointestinal tract. We have eliminated these problems by using RASVs with regulated delayed expression of attenuation and regulated delayed synthesis of recombinant antigens. These changes result in RASVs that colonize effector lymphoid tissues efficiently to serve as "factories" to synthesize protective antigens that induce higher protective immune responses than achieved when using previously constructed RASVs. We have devised a biological containment system with regulated delayed lysis to preclude RASV persistence in vivo and survival if excreted. Attributes were added to reduce the mild diarrhea sometimes experienced with oral live RASVs and to ensure complete safety in newborns. These collective technologies have been used to develop a novel, low-cost, RASV-synthesizing, multiple-protective Streptococcus pneumoniae antigens that will be safe for newborns/infants and will induce protective immunity to diverse S. pneumoniae serotypes after oral immunization.

REFERENZIERT VON
  1. Chandra Subhash, Faisal Syed M., Chen Jenn-Wei, Chen Tsai-Tzu, McDonough Sean P., Liu Sen, Moreira Maria A.S., Akey Bruce L., Chang Chao-Fu, Chang Yung-Fu, Immune response and protective efficacy of live attenuated Salmonella vaccine expressing antigens of Mycobacterium avium subsp. paratuberculosis against challenge in mice, Vaccine, 31, 1, 2012. Crossref

  2. Galen James E, Simon Raphael, Ernst Robert K, Salmonellaexpressing detoxified lipopolysaccharide is immunogenic and protective both as an attenuated vaccine and for delivery of foreign antigens, Expert Review of Vaccines, 10, 12, 2011. Crossref

  3. Wang Shifeng, Kong Qingke, Curtiss Roy, New technologies in developing recombinant attenuated Salmonella vaccine vectors, Microbial Pathogenesis, 58, 2013. Crossref

  4. Frey Sharon E., Lottenbach Kathleen R., Hill Heather, Blevins Tamara P., Yu Yinyi, Zhang Ying, Brenneman Karen E., Kelly-Aehle Sandra M., McDonald Caitlin, Jansen Angela, Curtiss Roy, A Phase I, dose-escalation trial in adults of three recombinant attenuated Salmonella Typhi vaccine vectors producing Streptococcus pneumoniae surface protein antigen PspA, Vaccine, 31, 42, 2013. Crossref

  5. Galen James E., Curtiss Roy, The delicate balance in genetically engineering live vaccines, Vaccine, 32, 35, 2014. Crossref

  6. Naz Rajesh K, Recent progress toward development of vaccines against conception, Expert Review of Vaccines, 13, 1, 2014. Crossref

  7. Roland Kenneth L, Brenneman Karen E, Salmonellaas a vaccine delivery vehicle, Expert Review of Vaccines, 12, 9, 2013. Crossref

  8. Kong Wei, Clark-Curtiss Josephine, Curtiss III Roy, Utilizing Salmonella for antigen delivery: the aims and benefits of bacterial delivered vaccination, Expert Review of Vaccines, 12, 4, 2013. Crossref

  9. Sizemore Donata R., Warner Elizabeth A., Lawrence Julie A., Thomas Lawrence J., Roland Kenneth L., Killeen Kevin P., Construction and screening of attenuated ΔphoP/Q Salmonella typhimuriumvectored plague vaccine candidates, Human Vaccines & Immunotherapeutics, 8, 3, 2012. Crossref

  10. Carleton Heather A., Lara-Tejero María, Liu Xiaoyun, Galán Jorge E., Engineering the type III secretion system in non-replicating bacterial minicells for antigen delivery, Nature Communications, 4, 1, 2013. Crossref

  11. Jenikova Gabriela, Hruz Petr, Andersson Mattias K., Tejman-Yarden Noa, Ferreira Patricia C.D., Andersen Yolanda S., Davids Barbara J., Gillin Frances D., Svärd Staffan G., Curtiss Roy, Eckmann Lars, α1-giardin based live heterologous vaccine protects against Giardia lamblia infection in a murine model, Vaccine, 29, 51, 2011. Crossref

  12. Pascual David W, Suo Zhiyong, Cao Ling, Avci Recep, Yang Xinghong, Attenuating gene expression (AGE) for vaccine development, Virulence, 4, 5, 2013. Crossref

  13. Heithoff Douglas M., House John K., Thomson Peter C., Mahan Michael J., Development of a Salmonella cross-protective vaccine for food animal production systems, Vaccine, 33, 1, 2015. Crossref

  14. Han Y.-G., Liang A.-X., Han L., Guo A.-Z., Jiang X.-P., Yang L.-G., Efficacy and Safety of an Oral Somatostatin DNA Vaccine without Antibiotic Resistance Gene in Promoting Growth of Piglets, Scandinavian Journal of Immunology, 79, 4, 2014. Crossref

  15. Torres Alfredo G., Rudra Jai S., Milligan Gregg N., Microbial-Based and Material-Based Vaccine Delivery Systems, in Vaccinology, 2014. Crossref

  16. Roos Karen, Werner Esther, Loessner Holger, Multicopy integration of mini-Tn7 transposons into selected chromosomal sites of aSalmonellavaccine strain, Microbial Biotechnology, 8, 1, 2015. Crossref

  17. Pascual David W, Yang Xinghong, Holderness Kathryn, Jun SangMu, Maddaloni Massimo, Kochetkova Irina, Regulatory T-cell vaccination independent of auto-antigen, Experimental & Molecular Medicine, 46, 3, 2014. Crossref

  18. Wang Shifeng, Curtiss III Roy, Development of Streptococcus pneumoniae Vaccines Using Live Vectors, Vaccines, 2, 1, 2014. Crossref

  19. Ando Hiroki, Citorik Robert, Cleto Sara, Lemire Sebastien, Mimee Mark, Lu Timothy, Synthetic Biology and Therapies for Infectious Diseases, in Novel Antimicrobial Agents and Strategies, 2014. Crossref

  20. McSorley Stephen J., Immunity to intestinal pathogens: lessons learned fromSalmonella, Immunological Reviews, 260, 1, 2014. Crossref

  21. Husseiny Mohamed I., Rawson Jeffrey, Kaye Alexander, Nair Indu, Todorov Ivan, Hensel Michael, Kandeel Fouad, Ferreri Kevin, An oral vaccine for type 1 diabetes based on live attenuated Salmonella, Vaccine, 32, 20, 2014. Crossref

  22. Pasetti Marcela F., Simon Jakub K., Sztein Marcelo B., Levine Myron M., Immunology of gut mucosal vaccines, Immunological Reviews, 239, 1, 2011. Crossref

  23. Curtiss Roy, Antigen Delivery System II, in Mucosal Immunology, 2015. Crossref

  24. Levine Myron M., “IDEAL” vaccines for resource poor settings, Vaccine, 29, 2011. Crossref

  25. Laughlin Richard C., Mickum Megan, Rowin Kristina, Adams L. Garry, Alaniz Robert C., Altered host immune responses to membrane vesicles from Salmonella and Gram-negative pathogens, Vaccine, 33, 38, 2015. Crossref

  26. Karpenko Larisa I., Danilenko Alexey V., Bazhan Sergei I., Danilenko Elena D., Sysoeva Galina M., Kaplina Olga N., Volkova Olga Y., Oreshkova Svetlana F., Ilyichev Alexander A., Attenuated Salmonella enteritidis E23 as a vehicle for the rectal delivery of DNA vaccine coding for HIV-1 polyepitope CTL immunogen, Microbial Biotechnology, 5, 2, 2012. Crossref

  27. Moffitt Kristin L, Malley Richard, Next generation pneumococcal vaccines, Current Opinion in Immunology, 23, 3, 2011. Crossref

  28. Zheng Y, Xiao Y, Wu H, Wang Q, Xiao J, Zhang Y, Liu Q, Different approaches to expressing Edwardsiella tarda antigen GAPDH in attenuated Vibrio anguillarum for multivalent fish vaccines, Journal of Fish Diseases, 35, 8, 2012. Crossref

  29. Aehle Sandra, Curtiss Roy, Current and Future Perspectives on Development of Salmonella Vaccine Technologies, in Producing Safe Eggs, 2017. Crossref

  30. Barrila Jennifer, Wilson James W., Soni Anjali, Yang Jiseon, Mark Ott C., Nickerson Cheryl A., Using Spaceflight and Spaceflight Analogue Culture for Novel Mechanistic Insight into Salmonella Pathogenesis, in Effect of Spaceflight and Spaceflight Analogue Culture on Human and Microbial Cells, 2016. Crossref

  31. Sanapala Shilpa, Rahav Hannah, Patel Hetal, Sun Wei, Curtiss Roy, Multiple antigens of Yersinia pestis delivered by live recombinant attenuated Salmonella vaccine strains elicit protective immunity against plague, Vaccine, 34, 21, 2016. Crossref

  32. Sun Wei, Plague Vaccines: Status and Future, in Yersinia pestis: Retrospective and Perspective, 918, 2016. Crossref

  33. Rosche Kristin L., Aljasham Alanoud T., Kipfer James N., Piatkowski Bryan T., Konjufca Vjollca, Moser Muriel, Infection with Salmonella enterica Serovar Typhimurium Leads to Increased Proportions of F4/80+ Red Pulp Macrophages and Decreased Proportions of B and T Lymphocytes in the Spleen, PLOS ONE, 10, 6, 2015. Crossref

  34. Felgner Sebastian, Kocijancic Dino, Frahm Michael, Curtiss Roy, Erhardt Marc, Weiss Siegfried, OptimizingSalmonella entericaserovar Typhimurium for bacteria-mediated tumor therapy, Gut Microbes, 7, 2, 2016. Crossref

  35. Clark-Curtiss Josephine E., Curtiss Roy, SalmonellaVaccines: Conduits for Protective Antigens, The Journal of Immunology, 200, 1, 2018. Crossref

  36. Farhadi Tayebeh, Hashemian Seyed MohammadReza, Constructing novel chimeric DNA vaccine against Salmonella enterica based on SopB and GroEL proteins: an in silico approach, Journal of Pharmaceutical Investigation, 48, 6, 2018. Crossref

  37. Kim Min Sun, Choi Seung Hyuk, Yang Jeong In, Kim Ki Hong, Production of RNase III-knockout, auxotrophic Edwardsiella tarda mutant for delivery of long double-stranded RNA and evaluation of its immunostimulatory potential, Fish & Shellfish Immunology, 68, 2017. Crossref

  38. Won Gayeon, Hajam Irshad Ahmed, Lee John Hwa, Improved lysis efficiency and immunogenicity of Salmonella ghosts mediated by co-expression of λ phage holin-endolysin and ɸX174 gene E, Scientific Reports, 7, 1, 2017. Crossref

  39. Nascimento I.P., Leite L.C.C., Recombinant vaccines and the development of new vaccine strategies, Brazilian Journal of Medical and Biological Research, 45, 12, 2012. Crossref

  40. Zhang Xiangmin, Kong Wei, Wanda Soo-Young, Xin Wei, Alamuri Praveen, Curtiss Roy, Schmolke Mirco, Generation of Influenza Virus from Avian Cells Infected by Salmonella Carrying the Viral Genome, PLOS ONE, 10, 3, 2015. Crossref

  41. Maddux Jacob T., Stromberg Zachary R., Curtiss III Roy, Mellata Melha, Evaluation of Recombinant Attenuated Salmonella Vaccine Strains for Broad Protection against Extraintestinal Pathogenic Escherichia coli, Frontiers in Immunology, 8, 2017. Crossref

  42. Husseiny Mohamed I., Du Weiting, Mbongue Jacques, Lenz Ayelet, Rawson Jeffrey, Kandeel Fouad, Ferreri Kevin, Factors affecting Salmonella-based combination immunotherapy for prevention of type 1 diabetes in non-obese diabetic mice, Vaccine, 36, 52, 2018. Crossref

  43. Jennings Matthew E., Quick Laura N., Soni Anjali, Davis Richard R., Crosby Kathleen, Ott C. Mark, Nickerson Cheryl A., Wilson James W., Characterization of the Salmonella enterica Serovar Typhimurium ydcI Gene, Which Encodes a Conserved DNA Binding Protein Required for Full Acid Stress Resistance , Journal of Bacteriology, 193, 9, 2011. Crossref

  44. Lottenbach Kathleen R., Kelly-Aehle Sandra M., Brenneman Karen E., Curtiss Roy, Frey Sharon E., Rapid, Sensitive Recovery of Recombinant Attenuated Salmonella enterica Serovar Typhi Vaccine Strains from Human Blood, Clinical and Vaccine Immunology, 20, 9, 2013. Crossref

  45. Redweik Graham A.J., Stromberg Zachary R., Van Goor Angelica, Mellata Melha, Protection against avian pathogenic Escherichia coli and Salmonella Kentucky exhibited in chickens given both probiotics and live Salmonella vaccine, Poultry Science, 99, 2, 2020. Crossref

  46. Nevermann Jan, Silva Andrés, Otero Carolina, Oyarzún Diego P., Barrera Boris, Gil Fernando, Calderón Iván L., Fuentes Juan A., Identification of Genes Involved in Biogenesis of Outer Membrane Vesicles (OMVs) in Salmonella enterica Serovar Typhi, Frontiers in Microbiology, 10, 2019. Crossref

  47. A perspective on the 2009 A/H1N1 influenza pandemic in Mexico, Mathematical Biosciences and Engineering, 8, 1, 2011. Crossref

  48. The impact of vaccines and vaccinations: Challenges and opportunities for modelers, Mathematical Biosciences and Engineering, 8, 1, 2011. Crossref

  49. Gao X., Xu K., Yang G., Shi C., Huang H., Wang J., Yang W., Liu J., Liu Q., Kang Y., Jiang Y., Wang C., Construction of a novelDNAvaccine candidate targeting F gene of genotypeVIINewcastle disease virus and chickenIL‐18 delivered bySalmonella, Journal of Applied Microbiology, 126, 5, 2019. Crossref

  50. Ott C. Mark, Crabbé Aurélie, Wilson James W., Barrila Jennifer, Castro-Wallace Sarah L., Nickerson Cheryl A., Microbial Stress: Spaceflight-Induced Alterations in Microbial Virulence and Infectious Disease Risks for the Crew, in Stress Challenges and Immunity in Space, 2020. Crossref

  51. Liang Kang, Liu Qing, Li Pei, Luo Hongyan, Wang Haoju, Kong Qingke, Genetically engineered Salmonella Typhimurium: Recent advances in cancer therapy, Cancer Letters, 448, 2019. Crossref

  52. Liu Qing, Li Pei, Luo Hongyan, Curtiss Roy, Kong Qingke, Attenuated Salmonella Typhimurium expressing Salmonella Paratyphoid A O-antigen induces protective immune responses against two Salmonella strains, Virulence, 10, 1, 2019. Crossref

  53. Loessner Holger, Schwantes Astrid, Hamdorf Matthias, Komor Uliana, Leschner Sara, Weiss Siegfried, Employing Live Microbes for Vaccine Delivery, in Development of Novel Vaccines, 2012. Crossref

  54. Kong Qingke, Six David A., Roland Kenneth L., Liu Qing, Gu Lillian, Reynolds C. Michael, Wang Xiaoyuan, Raetz Christian R. H., Curtiss Roy, SalmonellaSynthesizing 1-Monophosphorylated Lipopolysaccharide Exhibits Low Endotoxic Activity while Retaining Its Immunogenicity, The Journal of Immunology, 187, 1, 2011. Crossref

  55. Redweik Graham A. J., Daniels Karrie, Severin Andrew J., Lyte Mark, Mellata Melha, Oral Treatments With Probiotics and Live Salmonella Vaccine Induce Unique Changes in Gut Neurochemicals and Microbiome in Chickens, Frontiers in Microbiology, 10, 2020. Crossref

  56. Liang Kang, Liu Qing, Kong Qingke, New technologies in developing recombinant‐attenuated bacteria for cancer therapy, Biotechnology and Bioengineering, 118, 2, 2021. Crossref

  57. Brenneman Karen E, Gonzales Amanda, Roland Kenneth L, Curtiss Roy, Use of Ensure® nutrition shakes as an alternative formulation method for live recombinant Attenuated Salmonella Typhi vaccines, BMC Microbiology, 15, 1, 2015. Crossref

  58. Mahan Michael J, Heithoff Douglas M, House John K, Salmonella cross-protective vaccines: fast-forward to the next generation of food safety, Future Microbiology, 7, 7, 2012. Crossref

  59. Guan Lingyu, Liu Qin, Li Chao, Zhang Yuanxing, Development of a Fur-dependent and tightly regulated expression system in Escherichia colifor toxic protein synthesis, BMC Biotechnology, 13, 1, 2013. Crossref

  60. Samakchan Natthapon, Thinwang Patipat, Boonyom Rerngwit, Oral immunization of rat with chromosomal expression LipL32 in attenuated Salmonella vaccine induces immune respond against pathogenic Leptospira, Clinical and Experimental Vaccine Research, 10, 3, 2021. Crossref

  61. Hegazy Wael Abdel Halim, Hensel Michael, Salmonella enterica as a vaccine carrier, Future Microbiology, 7, 1, 2012. Crossref

  62. McMullan Niall, Vaccine Design and Vaccination, in Molecular and Cellular Therapeutics, 2012. Crossref

  63. Kong Qingke, Yang Jiseon, Liu Qing, Alamuri Praveen, Roland Kenneth L., Curtiss Roy, McCormick B. A., Effect of Deletion of Genes Involved in Lipopolysaccharide Core and O-Antigen Synthesis on Virulence and Immunogenicity of Salmonella enterica Serovar Typhimurium, Infection and Immunity, 79, 10, 2011. Crossref

  64. Xin Wei, Wanda Soo-Young, Zhang Xiangmin, Santander Javier, Scarpellini Giorgio, Ellis Karen, Alamuri Praveen, Curtiss Roy, Camilli A., The Asd + -DadB + Dual-Plasmid System Offers a Novel Means To Deliver Multiple Protective Antigens by a Recombinant Attenuated Salmonella Vaccine , Infection and Immunity, 80, 10, 2012. Crossref

  65. Wang Shifeng, Hofacre Charles L., Wanda Soo-Young, Zhou Jingyu, Callum Richard A., Nordgren Bob, Curtiss Roy, A triple-sugar regulated Salmonella vaccine protects against Clostridium perfringens-induced necrotic enteritis in broiler chickens, Poultry Science, 101, 2, 2022. Crossref

  66. Kong Wei, Brovold Matthew, Koeneman Brian A., Clark-Curtiss Josephine, Curtiss Roy, Turning self-destructing Salmonella into a universal DNA vaccine delivery platform , Proceedings of the National Academy of Sciences, 109, 47, 2012. Crossref

  67. Su Huali, Liu Qing, Bian Xiaoping, Wang Shifeng, Curtiss Roy, Kong Qingke, Synthesis and delivery of Streptococcus pneumoniae capsular polysaccharides by recombinant attenuated Salmonella vaccines , Proceedings of the National Academy of Sciences, 118, 2, 2021. Crossref

  68. Felgner Sebastian, Frahm Michael, Kocijancic Dino, Rohde Manfred, Eckweiler Denitsa, Bielecka Agata, Bueno Emilio, Cava Felipe, Abraham Wolf-Rainer, Curtiss Roy, Häussler Susanne, Erhardt Marc, Weiss Siegfried, Kaufmann Stefan H. E., aroA -Deficient Salmonella enterica Serovar Typhimurium Is More Than a Metabolically Attenuated Mutant , mBio, 7, 5, 2016. Crossref

  69. Juárez-Rodríguez María Dolores, Arteaga-Cortés Lourdes T., Kader Rebin, Curtiss Roy, Clark-Curtiss Josephine E., Camilli A., Live Attenuated Salmonella Vaccines against Mycobacterium tuberculosis with Antigen Delivery via the Type III Secretion System, Infection and Immunity, 80, 2, 2012. Crossref

  70. Juárez-Rodríguez María Dolores, Yang Jiseon, Kader Rebin, Alamuri Praveen, Curtiss Roy, Clark-Curtiss Josephine E., Camilli A., Live Attenuated Salmonella Vaccines Displaying Regulated Delayed Lysis and Delayed Antigen Synthesis To Confer Protection against Mycobacterium tuberculosis, Infection and Immunity, 80, 2, 2012. Crossref

  71. Galen James E., Wang Jin Yuan, Carrasco Jose A., Lloyd Scott A., Mellado-Sanchez Gabriela, Diaz-McNair Jovita, Franco Olga, Buskirk Amanda D., Nataro James P., Pasetti Marcela F., Bäumler A. J., A Bivalent Typhoid Live Vector Vaccine Expressing both Chromosome- and Plasmid-Encoded Yersinia pestis Antigens Fully Protects against Murine Lethal Pulmonary Plague Infection, Infection and Immunity, 83, 1, 2015. Crossref

  72. Wang Shifeng, Shi Huoying, Li Yuhua, Shi Zhaoxing, Zhang Xin, Baek Chang-Ho, Mothershead Tabor, Curtiss Roy, Camilli A., A Colanic Acid Operon Deletion Mutation Enhances Induction of Early Antibody Responses by Live Attenuated Salmonella Vaccine Strains, Infection and Immunity, 81, 9, 2013. Crossref

  73. Guan Lingyu, Mu Wei, Champeimont Jonathan, Wang Qiyao, Wu Haizhen, Xiao Jingfan, Lubitz Werner, Zhang Yuanxing, Liu Qin, Payne S. M., Iron-Regulated Lysis of Recombinant Escherichia coli in Host Releases Protective Antigen and Confers Biological Containment, Infection and Immunity, 79, 7, 2011. Crossref

  74. Kong Wei, Development of Antiviral Vaccine Utilizing Self-Destructing Salmonella for Antigen and DNA Vaccine Delivery, in Viruses as Therapeutics, 2225, 2021. Crossref

  75. Ghasemi Amir, Wang Shifeng, Sahay Bikash, Abbott Jeffrey R., Curtiss Roy, Protective immunity enhanced Salmonella vaccine vectors delivering Helicobacter pylori antigens reduce H. pylori stomach colonization in mice, Frontiers in Immunology, 13, 2022. Crossref

  76. Dieye Yakhya, Nguer Cheikh Momar, Thiam Fatou, Diouara Abou Abdallah Malick, Fall Cheikh, Recombinant Helicobacter pylori Vaccine Delivery Vehicle: A Promising Tool to Treat Infections and Combat Antimicrobial Resistance, Antibiotics, 11, 12, 2022. Crossref

Zukünftige Artikel

Identification of a novel five-gene prognostic model for laryngeal cancer associated with mitophagy using integrated bioinformatics analysis and experimental verification Dong Song, Lun Dong, Mei Wang, Xiaoping Gao Function of steroid receptor coactivators (SRCs) in T cells and cancers: Implications for cancer immunotherapy Wencan Zhang, Xu Cao, Hongmin Wu, Xiancai Zhong, Yun Shi, Zuoming Sun Electroacupuncture Alleviates Ischemic Stroke by Activating the mTOR/SREBP1 Pathway Jiawang Lang, Jianchang Luo, Luodan Wang, Wenbin Xu, Jie Jia, Zhipeng Zhao, Boxu Lang KIAA1429 induces the m6A modification of LINC01106 to enhance the malignancy of lung adenocarcinoma cell via JAK/STAT3 pathway Di Xu, Ziming Wang, Fajiu Li Effect of p-estrogen receptor at serine on its function and breast growth Yuan Liang, Junhui Qin, Tiancheng Ma, Tong Yang, Zhenyu Ke, Ruian Wang Mechanistic Insights into Tanshinone IIA in the Amelioration of Post-Thyroidectomy Hypoparathyroidism Xiaoyu Qian, Lin Li, Liang Chen, Chao Shen, Jian Tang MiRNA let-7d-5p alleviates inflammatory responses by targeting Map3k1 and inactivating ERK/p38 MAPK signaling in microglia Fan Fang, Cheng Chen Role of Natural Killer Cells as Cell-Based Immunotherapy in Oral Tumor Eradication and Differentiation Both In Vivo and In Vitro Kawaljit Kaur, Anahid Jewett The Current and Future States of Natural Killer Cell-Based Immunotherapy in Hepatocellular Carcinoma Tu Nguyen, Po-Chun Chen, Janet Pham, Kawaljit Kaur, Steven Raman, Anahid Jewett, Jason Chiang Phillygenin alleviated arthritis through the inhibition of NLRP3 inflammasome and Ferroptosis by AMPK Jianghui Wang, Shufang Ni, Kai Zheng, Yan Zhao, peihong zhang, Hong Chang The value of systemic immune-inflammation index and T cell subsets in the severity and prognosis of sepsis Hao Zhou Efficacy and Nuances of Precision Molecular Engineering for Hodgkin's Disease to a Gene Therapeutic Approach Muhammad Imran Qadir, Bilal Ahmed, Nadir Hussain Serum interleukin 6 and ferritin levels are the independent risk factors for pneumonia in elderly patients Hao Yuan, Jing Tian, Lu Wen Exploration of diagnostic markers associated with inflammation in chronic kidney disease (CKD) based on WGCNA and machine learning Qianjia Wu, Yang Yang, Chongze Lin Clinical significance of serum CTRP3 level in the prediction of cardiac dysfunction and intestinal mucosal barrier dysfunction in patients with severe acute pancreatitis Qiang Shao, Lin Sun The protective effect and mechanism of mild hypothermia on pig lung injury after cardiopulmonary resuscitation Jinlin Ren, Fangfang Zhu, Dongdong Sang, Mulin Cong, Shujuan Jiang Exploring mechanism of Zilongjin in treating lung adenocarcinoma based on network pharmacology combined with experimental verification Kang Zhang, Xiaoqun Chen Gastric Cancer Immune Subtypes and Prognostic Modeling: Insights from Aging-Related Genes Analysis Jian Shen, Minzhe Li Effects of different doses of dexmedetomidine on the prevention of postoperative sleep disturbance and serum neurotransmitter level in patients under general anesthesia Huifei Lu, Fei He, Ying Huang, Zhongliang Wei Identification of key ubiquitination-related genes and their associated with immune infiltration in osteoarthritis based on mRNA-miRNA network Dalu Yuan, Hailiang Shen, Lina Bai, Menglin Li, Qiujie Ye Diagnostic and Prognostic value of peripheral neutrophil CD64 index in elderly patients with community-acquired pneumonia Yan Li, Jing Zhang, Suhang Wang, Jie Cao Identification of Metabolism-Related Prognostic Biomarkers and Immune Features of Head and Neck Squamous Cell Carcinoma Rongjin Zhou, Junguo Wang Downregulation of miR-503-5p promotes the development of pancreatic cancer via targeting cyclin E2 Fei Li, Ying-pei Ling, Pan Wang, Shi-cheng Gu, Hao Jiang, Jie Zhu
Digitales Portal Digitale Bibliothek eBooks Zeitschriften Referenzen und Berichte Forschungssammlungen Preise und Aborichtlinien Begell House Kontakt Language English 中文 Русский Português German French Spain